ESR1 and neoplasm: Furthermore, of the six clinicopathological parameters studied (tumor grade, age, menopause status, ER, PR, and HER2), CLN3 overexpression was significantly associated with absence of HER2 expression (p = 0.045) in patients with IDC of the breast (Table 2).